Vineet Agrawal, M.D., Ph.D., is the 2020 recipient of the Pulmonary Hypertension Association’s Aldrighetti Research Award for Young Investigators. Dr. Agrawal is a physician-scientist and instructor of medicine at Vanderbilt University Medical Center.
Did you miss the first event in the Pulmonary Hypertension Association (PHA)’s new virtual series, “PHA Live?” On Jan. 29, pulmonary hypertension experts answered questions about COVID-19 vaccines in Facebook Live discussions. Fernando Torres, M.D., led a Spanish-language Q&A, and Victor Tapson, M.D., FCCP, FRCP, led the English-language event.
One way to make a lasting impact on the pulmonary hypertension (PH) community is by joining the Pulmonary Hypertension Association’s planned giving program. Members of PHA’s Legacy of Hope support PHA’s future through wills, insurance policies, retirement accounts or trusts.
Join the Pulmonary Hypertension Association (PHA) Friday, Jan. 29 for Facebook Live discussions on COVID-19 vaccines in English and Spanish. Our new monthly PHA Live series begins at noon Friday with a Spanish-language Q&A with Fernando Torres, M.D. An English language Q&A with Victor Tapson, M.D., FCCP, FRCP, will follow at 1 p.m.
A new assistance fund is available to help pay pulmonary hypertension (PH) health care costs. The HealthWell Foundation’s PH fund is now open to Medicare recipients, including those with Medicare Advantage plans. Assistance grants can be used for Medicare coverage premiums and PH medication copays.
John Raleigh Chowning's beautiful voice and natural talent for the guitar inspired his mother to take up running after his 2011 death to pulmonary hypertension (PH). Since then, she finds purpose in running in his memory and raising money to fight PH.
The HealthWell Foundation launched a pulmonary hypertension (PH) assistance fund Monday, January 11. The fund is open to Medicare recipients, including those with Medicare Advantage plans. Assistance grants can be used to cover the premium costs of purchasing Medicare coverage or to cover copay expenses for PH medication.
As we enter 2021, the Pulmonary Hypertension Association (PHA) welcomes important milestones and new beginnings. The new year marks the start of PHA’s 30th anniversary, the launch of COVID-19 vaccines in the United States and signs of an eventual return to post-pandemic life. In this remarkable time, I am delighted to join PHA as its third president and CEO.